191 related articles for article (PubMed ID: 16956561)
1. [Epidermal growth factor receptor inhibitors side effects].
Guhl G; González-de Arriba A; Daudén E
Actas Dermosifiliogr; 2006 Jun; 97(5):296-310. PubMed ID: 16956561
[TBL] [Abstract][Full Text] [Related]
2. [Acneiform eruption from epidermal growth factor receptor inhibitors].
Martínez de Lagrán Z; Ratón JA; Lasa O; Acebo E; Díaz-Pérez JL
Actas Dermosifiliogr; 2005 Sep; 96(7):450-4. PubMed ID: 16476273
[TBL] [Abstract][Full Text] [Related]
3. [Contribution to acneiform eruptions by epidermal growth factor receptor inhibitors].
Bodet D; Bartralot R; Mollet J; Heras C; García-Patos V
Actas Dermosifiliogr; 2006 Mar; 97(2):148-9. PubMed ID: 16595122
[No Abstract] [Full Text] [Related]
4. Severe EGFR inhibitor-induced acneiform eruption responding to dapsone.
Beshay A; Petersen M; Rhoads JLW
Dermatol Online J; 2021 Jul; 27(7):. PubMed ID: 34391331
[TBL] [Abstract][Full Text] [Related]
5. Severe acneiform skin reaction during therapy with erlotinib (Tarceva), an epidermal growth factor receptor (EGFR) inhibitor.
Eames T; Landthaler M; Karrer S
Eur J Dermatol; 2007; 17(6):552-3. PubMed ID: 17951151
[No Abstract] [Full Text] [Related]
6. Images in clinical medicine. Cetuximab-associated acneiform eruption.
Moss JE; Burtness B
N Engl J Med; 2005 Nov; 353(19):e17. PubMed ID: 16282170
[No Abstract] [Full Text] [Related]
7. Acneiform rash due to epidermal growth factor receptor inhibitors: high-level laser therapy as an innovative approach.
Gobbo M; Ottaviani G; Mustacchi G; Di Lenarda R; Biasotto M
Lasers Med Sci; 2012 Sep; 27(5):1085-90. PubMed ID: 22120470
[TBL] [Abstract][Full Text] [Related]
8. Erlotinib-related skin toxicities: treatment strategies in patients with metastatic non-small cell lung cancer.
Kiyohara Y; Yamazaki N; Kishi A
J Am Acad Dermatol; 2013 Sep; 69(3):463-72. PubMed ID: 23602600
[TBL] [Abstract][Full Text] [Related]
9. Cetuximab-induced acneiform eruption and the response to isotretinoin.
Vezzoli P; Marzano AV; Onida F; Alessi E; Galassi B; Tomirotti M; Berti E
Acta Derm Venereol; 2008; 88(1):84-6. PubMed ID: 18176767
[No Abstract] [Full Text] [Related]
10. Acneiform lesions secondary to ZD1839, an inhibitor of the epidermal growth factor receptor.
Fernandez-Galar M; España A; López-Picazo JM
Clin Exp Dermatol; 2004 Mar; 29(2):138-40. PubMed ID: 14987267
[TBL] [Abstract][Full Text] [Related]
11. Follicular and epidermal alterations in patients treated with ZD1839 (Iressa), an inhibitor of the epidermal growth factor receptor.
Van Doorn R; Kirtschig G; Scheffer E; Stoof TJ; Giaccone G
Br J Dermatol; 2002 Sep; 147(3):598-601. PubMed ID: 12207609
[TBL] [Abstract][Full Text] [Related]
12. Markers in the epidermal growth factor receptor pathway and skin toxicity during erlotinib treatment.
Tan AR; Steinberg SM; Parr AL; Nguyen D; Yang SX
Ann Oncol; 2008 Jan; 19(1):185-90. PubMed ID: 17878175
[TBL] [Abstract][Full Text] [Related]
13. Vitamin K1 cream significantly reduces incidence and severity of cetuximab-related acneiform skin rash in women: a post hoc analysis of the EVITA trial.
Gaiser MR; Lorenzen S; Merx K; Trojan J; Ocvirk J; Ettrich TJ; Al-Batran SE; Schulz H; Homann N; Feustel HP; Schatz M; Kripp M; Schulte N; Heeger S; Vlassak S; Koch W; Hofheinz RD
Ann Oncol; 2018 Dec; 29(12):2393-2395. PubMed ID: 30307464
[No Abstract] [Full Text] [Related]
14. Papulopustular acneiform eruptions resulting from trastuzumab, a HER2 inhibitor.
Sheu J; Hawryluk EB; Litsas G; Thakuria M; LeBoeuf NR
Clin Breast Cancer; 2015 Feb; 15(1):e77-81. PubMed ID: 25445421
[No Abstract] [Full Text] [Related]
15. Management of Dermatologic Complications of Lung Cancer Therapies.
Pugliese SB; Neal JW; Kwong BY
Curr Treat Options Oncol; 2015 Oct; 16(10):50. PubMed ID: 26338208
[TBL] [Abstract][Full Text] [Related]
16. Purpuric Drug Eruptions Caused by Epidermal Growth Factor Receptor Inhibitors for Non-Small Cell Lung Cancer: A Clinicopathologic Study of 32 Cases.
Cho YT; Chen KL; Sheen YS; Yang CW; Liau JY; Cheng YP; Chu CY
JAMA Dermatol; 2017 Sep; 153(9):906-910. PubMed ID: 28538945
[TBL] [Abstract][Full Text] [Related]
17. Acneiform eruptions induced by epidermal growth factor receptor inhibitors: treatment with oral isotretinoin.
Requena C; Llombart B; Sanmartín O
Cutis; 2012 Aug; 90(2):77-80. PubMed ID: 22988651
[TBL] [Abstract][Full Text] [Related]
18. [Therapy of severe cetuximab-induced acneiform eruptions with oral retinoid, topical antibiotic and topical corticosteroid].
Wollenberg A; Moosmann N; Kroth J; Heinemann V; Klein E
Hautarzt; 2007 Jul; 58(7):615-8. PubMed ID: 17146641
[TBL] [Abstract][Full Text] [Related]
19. Management of cutaneous side-effects of cetuximab therapy in patients with metastatic colorectal cancer.
Ocvirk J; Cencelj S
J Eur Acad Dermatol Venereol; 2010 Apr; 24(4):453-9. PubMed ID: 19793151
[TBL] [Abstract][Full Text] [Related]
20. EGFR inhibitors: clinical aspects, risk factors and biomarkers for acneiform eruptions and other mucosal and cutaneous adverse effects.
Recuero JK; Fitz JR; Pereira AA; Bonamigo RR
An Bras Dermatol; 2023; 98(4):429-439. PubMed ID: 36990917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
